Tatva Chintan

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE0GK401011
  • NSEID: TATVA
  • BSEID: 543321
INR
1,090.10
-64.6 (-5.59%)
BSENSE

Feb 01

BSE+NSE Vol: 35.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003512,
    "name": "Tatva Chintan",
    "stock_name": "Tatva Chintan",
    "full_name": "Tatva Chintan Pharma Chem Ltd",
    "name_url": "stocks-analysis/tatva-chintan",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,090.10",
    "chg": -64.6,
    "chgp": "-5.59%",
    "dir": -1,
    "prev_price": "1,154.70",
    "mcapval": "2,660.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543321,
    "symbol": "TATVA",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE0GK401011",
    "curr_date": "Feb 01",
    "curr_time": "",
    "bse_nse_vol": "35.24 k",
    "exc_status": "Active",
    "traded_date": "Feb 01, 2026",
    "traded_date_str": "2026 02 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tatva-chintan-1003512-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-hold-3813968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TatvaChintanPha_mojoScore_3813968.png",
        "date": "2026-02-01 10:10:56",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-hits-intraday-low-amid-price-pressure-3813918",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TatvaChintanPha_priceRelatedfactors_3813918.png",
        "date": "2026-02-01 09:35:00",
        "description": "Tatva Chintan Pharma Chem Ltd experienced a significant intraday decline on 1 Feb 2026, with the stock touching a low of Rs 1123.7, down 11.79% from previous levels. This sharp fall reflects mounting price pressure and heightened volatility within the Specialty Chemicals sector, contrasting with the broader market’s relatively muted movement."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Falls 16.14%: 4 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-falls-1614-4-key-factors-driving-the-weekly-decline-3803192",
        "imagepath": "",
        "date": "2026-01-24 11:03:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Stock opens strong at Rs.1,407.60 (+2.08%) amid broader market weakness</p>\n                    <p><strong>Jan 21:</strong> Reports outstanding Q3 FY26 results, shares rise 1.36%</p>\n                    <p><strong>Jan 22:</strong> Intraday volatility with a sharp reversal; stock hits intraday low amid price pressure</p>\n                    <p><strong>Jan 23:</strong> Continued selling pressure leads to 7.14% drop, closing at Rs.1,156.30</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,378.90</div></div>\n                    <div class=\"s..."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-hits-intraday-low-amid-price-pressure-3801778",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TatvaChintanPha_priceRelatedfactors_3801778.png",
        "date": "2026-01-23 12:32:25",
        "description": "Tatva Chintan Pharma Chem Ltd experienced a notable decline today, touching an intraday low of Rs 1184.55, reflecting a sharp price correction amid broader market pressures and sector underperformance."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-hits-intraday-low-amid-price-pressure-3800271",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TatvaChintanPha_priceRelatedfactors_3800271.png",
        "date": "2026-01-22 12:16:33",
        "description": "Shares of Tatva Chintan Pharma Chem Ltd experienced significant intraday weakness on 22 Jan 2026, hitting a low of Rs 1,290.90, down 7.16% from the previous close. Despite opening with a 3% gain and touching an intraday high of Rs 1,494.65, the stock reversed sharply, underperforming its sector and broader market indices amid heightened volatility and selling pressure."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd Reports Outstanding Quarterly Financial Performance Amid Shifting Market Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/tatva-chintan-pharma-chem-ltd-reports-outstanding-quarterly-financial-performance-amid-shifting-market-trends-3799445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TatvaChintanPha_fintrenddot_3799445.png",
        "date": "2026-01-22 08:00:18",
        "description": "Tatva Chintan Pharma Chem Ltd has delivered an outstanding quarterly performance for the December 2025 quarter, marking a significant improvement in its financial trend from very positive to outstanding. The specialty chemicals company reported record-high net sales and profitability metrics, although some operational challenges remain. This article analyses the recent quarterly results in the context of historical trends and market performance."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-hold-3798157",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TatvaChintanPha_mojoScore_3798157.png",
        "date": "2026-01-21 10:10:37",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 January 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Tatva Chintan Pharma Chem Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-tatva-chintan-pharma-chem-ltd-3790625",
        "imagepath": "",
        "date": "2026-01-13 23:16:21",
        "description": "The next results date for Tatva Chintan Pharma Chem Ltd is scheduled for January 21, 2026...."
      },
      {
        "title": "Tatva Chintan Pharma Chem Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/tatva-chintan-pharma-chem-ltd-is-rated-hold-3787986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TatvaChintanPha_mojoScore_3787986.png",
        "date": "2026-01-10 10:10:35",
        "description": "Tatva Chintan Pharma Chem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 456,
    "sid": "1003512",
    "stock_news_url": "https://www.marketsmojo.com/news/tatva-chintan-pharma-chem-1003512"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011",
      "datetime": "29-Jan-2026",
      "details": "The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ajay Patel",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "24-Jan-2026",
      "details": "Transcript of the earnings call held on 21 January 2026 post announcement of the financial results of the Company for the quarter and nine months ended 31 December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "22-Jan-2026",
      "details": "Newspaper Publication of Extract of Financial Results of the Company for the Quarter and Nine Months ended 31 December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Tatva Chintan Pharma Chem Ltd has declared <strong>10%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Tatva Chintan Pharma Chem Ltd Falls 16.14%: 4 Key Factors Driving the Weekly Decline

2026-01-24 11:03:47

Key Events This Week

Jan 19: Stock opens strong at Rs.1,407.60 (+2.08%) amid broader market weakness

Jan 21: Reports outstanding Q3 FY26 results, shares rise 1.36%

Jan 22: Intraday volatility with a sharp reversal; stock hits intraday low amid price pressure

Jan 23: Continued selling pressure leads to 7.14% drop, closing at Rs.1,156.30

stock-recommendationAnnouncement

Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011

29-Jan-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Ajay Patel

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

24-Jan-2026 | Source : BSE

Transcript of the earnings call held on 21 January 2026 post announcement of the financial results of the Company for the quarter and nine months ended 31 December 2025.

Announcement under Regulation 30 (LODR)-Newspaper Publication

22-Jan-2026 | Source : BSE

Newspaper Publication of Extract of Financial Results of the Company for the Quarter and Nine Months ended 31 December 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tatva Chintan Pharma Chem Ltd has declared 10% dividend, ex-date: 12 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available